Clinical Trials
6
Trial Phases
2 Phases
Drug Approvals
9
Drug Approvals
HEPAXANE 4.000 UI (40 MG)/0,4 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA
- Approval Date
- Jul 14, 2025
HEPAXANE 12.000 UI (120 MG)/0,8 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA
- Approval Date
- Jul 14, 2025
STEOZOL 4 mg/5 ml CONCENTRADO PARA SOLUCION PARA PERFUSION EN JERINGA PRECARGADA
- Approval Date
- Jul 14, 2025
HEPAXANE 10.000 UI (100 MG)/1 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA
- Approval Date
- Jul 14, 2025
HEPAXANE 2.000 UI (20 MG)/0,2 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA
- Approval Date
- Jul 14, 2025
MUSTINAL 2.5 MG/ML POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
- Approval Date
- Jul 14, 2025
HEPAXANE 8.000 UI (80 MG)/0,8 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA
- Approval Date
- Jul 14, 2025
HEPAXANE 15.000 UI (150 MG)/1 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA
- Approval Date
- Jul 14, 2025
HEPAXANE 6.000 UI (60 MG)/0,6 ML SOLUCION INYECTABLE EN JERINGA PRECARGADA
- Approval Date
- Jul 14, 2025
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Extended-release of Octreotide (LF-PB) for the Treatment of Seroma
- Conditions
- Seroma
- Interventions
- Drug: extended release of octreotideDrug: extended release of placebo
- First Posted Date
- 2016-01-29
- Last Posted Date
- 2017-02-02
- Lead Sponsor
- Chemi S.p.A.
- Target Recruit Count
- 48
- Registration Number
- NCT02668588
- Locations
- 🇮🇹
Az. Osp. Univ. Mater Domini, Catanzaro, Calabria, Italy
🇮🇹IRCCS Fondazione Pascale, Naples, Campania, Italy
🇮🇹Az. Osp. Univ. di Ferrara - Ospedale di Cona, Ferrara, Emilia Romagna, Italy
Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c.
- Conditions
- Enoxaparin Sodium is Administered to Healthy Volunteers
- Interventions
- First Posted Date
- 2014-09-05
- Last Posted Date
- 2020-10-20
- Lead Sponsor
- Chemi S.p.A.
- Target Recruit Count
- 47
- Registration Number
- NCT02232802
- Locations
- 🇬🇧
Simbec Research Ltd, Merthyr Tydfil, United Kingdom
A Single-Dose Trial to Examine the Within Subject Variability of Clexane® in Healthy Adults Under Fasting Conditions
- Conditions
- Clexane is Administered to Healthy Volunteers
- First Posted Date
- 2014-03-07
- Last Posted Date
- 2020-11-12
- Lead Sponsor
- Chemi S.p.A.
- Target Recruit Count
- 14
- Registration Number
- NCT02081950
- Locations
- 🇬🇧
Simbec Research Ltd, Merthyr Tydfil, United Kingdom
Extended-release of Octreotide (LF-PB) for the Treatment of Lymphorrhea
- Conditions
- Lymphorrhea
- Interventions
- Drug: LF-PBDrug: PlaceboDrug: LF-PB and Placebo
- First Posted Date
- 2012-12-21
- Last Posted Date
- 2014-07-29
- Lead Sponsor
- Chemi S.p.A.
- Target Recruit Count
- 114
- Registration Number
- NCT01754285
- Locations
- 🇮🇹
Humanitas Centro Catanese di Oncologia Dipartimento di Oncologia -Chirurgia Oncologica Generale, Via V.E. Dabormida, 64, Catania, Italy
🇮🇹Fondazione per la Ricerca e la Cura dei Tumori "Tommaso Campanella" Unità Operativa Complessa CRR per il Counselling Genetico e le Terapie Innovative in Oncologia Medica, Viale Europa-Loc. Germaneto, Catanzaro, Italy
🇮🇹Azienda Ospedaliera OIRM Sant'Anna Dipartimento Funzionale di Oncologia - Breast Unit, Corso Spezia, 60 Torino, Italy